ATE467641T1 - Bibliothek von toxin mutanten und deren verwendung - Google Patents

Bibliothek von toxin mutanten und deren verwendung

Info

Publication number
ATE467641T1
ATE467641T1 AT04785852T AT04785852T ATE467641T1 AT E467641 T1 ATE467641 T1 AT E467641T1 AT 04785852 T AT04785852 T AT 04785852T AT 04785852 T AT04785852 T AT 04785852T AT E467641 T1 ATE467641 T1 AT E467641T1
Authority
AT
Austria
Prior art keywords
library
toxin mutants
mutants
toxin
libraries
Prior art date
Application number
AT04785852T
Other languages
English (en)
Inventor
Jean Gariepy
Xin Wei
Original Assignee
Molecular Templates Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Templates Inc filed Critical Molecular Templates Inc
Application granted granted Critical
Publication of ATE467641T1 publication Critical patent/ATE467641T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/25—Shigella (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT04785852T 2004-03-26 2004-03-26 Bibliothek von toxin mutanten und deren verwendung ATE467641T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CA2004/000443 WO2005092917A1 (en) 2004-03-26 2004-03-26 Library of toxin mutants, and methods of using same

Publications (1)

Publication Number Publication Date
ATE467641T1 true ATE467641T1 (de) 2010-05-15

Family

ID=34957323

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04785852T ATE467641T1 (de) 2004-03-26 2004-03-26 Bibliothek von toxin mutanten und deren verwendung

Country Status (9)

Country Link
US (1) US20070298434A1 (de)
EP (2) EP1727827B1 (de)
JP (1) JP4934761B2 (de)
AT (1) ATE467641T1 (de)
AU (1) AU2004317555B2 (de)
CA (1) CA2559536A1 (de)
DE (1) DE602004027168D1 (de)
ES (2) ES2386338T3 (de)
WO (1) WO2005092917A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2664549A1 (en) * 2005-09-26 2007-03-29 University Health Network Library from toxin mutants, and methods of using same
WO2007071061A1 (en) 2005-12-23 2007-06-28 Viventia Biotech Inc. Methods for generating and screening fusion protein libraries and uses thereof
CN111363047A (zh) 2013-03-12 2020-07-03 分子模板公司 用于引起细胞内化的cd20结合免疫毒素及其使用方法
ES2749862T3 (es) 2014-01-27 2020-03-24 Molecular Templates Inc Polipéptidos efectores desinmunizados de subunidad A de toxina Shiga para aplicaciones en mamíferos
JP6814634B2 (ja) 2014-02-05 2021-01-20 モレキュラー テンプレーツ, インク.Molecular Templates, Inc. リボ毒性の一時的な減少に基づき、細胞毒性組換えポリペプチドをスクリーニングし、選択し、同定する方法
US11142584B2 (en) 2014-03-11 2021-10-12 Molecular Templates, Inc. CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same
KR102496206B1 (ko) 2014-06-11 2023-02-06 몰레큘러 템플레이츠, 인코퍼레이션. 프로테아제-절단 저항성의 시가 독소 a 서브유닛 작동체 폴리펩티드 및 이를 포함하는 세포-표적화 분자
WO2016126950A1 (en) 2015-02-05 2016-08-11 Molecular Templates, Inc. Multivalent cd20-binding molecules comprising shiga toxin a subunit effector regions and enriched compositions thereof
CN114656573B (zh) 2015-05-30 2024-09-27 分子模板公司 去免疫化的志贺毒素a亚基支架和包含它们的细胞靶向分子
MX2018001208A (es) 2015-07-26 2018-03-26 Molecular Templates Inc Moleculas con direccion a las celulas que comprenden efectores de la subunidad a de la toxina shiga y epitopos de celulas-t cd8+.
MX2019006656A (es) 2016-12-07 2019-09-09 Molecular Templates Inc Polipeptidos efectores de la sub-unidad a de la toxina shiga andamiajes de los efectores de la toxina shiga y moleculas con direccion hacia las celulas para la conjugacion especifica del sitio.
KR102590672B1 (ko) 2017-01-25 2023-10-18 몰레큘러 템플레이츠, 인코퍼레이션. 탈면역된 시가 독소 a 서브유닛 이펙터 및 cd8+ t-세포 에피토프를 포함하는 세포-표적화 분자
KR20200143634A (ko) 2018-04-17 2020-12-24 몰레큘러 템플레이츠, 인코퍼레이션. 탈면역된 시가 독소 a 서브유닛 스캐폴드를 포함하는 her2-표적화 분자
WO2020081493A1 (en) 2018-10-16 2020-04-23 Molecular Templates, Inc. Pd-l1 binding proteins
WO2021055816A1 (en) 2019-09-18 2021-03-25 Molecular Templates, Inc. Pd-l1 binding molecules comprising shiga toxin a subunit scaffolds
US20210155671A1 (en) 2019-11-24 2021-05-27 Molecular Templates, Inc. Uses of cd20-binding molecules and additional therapeutic agents
EP4262858A1 (de) 2020-12-16 2023-10-25 Molecular Templates, Inc. Klinische verfahren zur verwendung eines pd-l1-bindenden moleküls mit einem shigatoxineffektor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5621083A (en) * 1991-11-04 1997-04-15 Xoma Corporation Immunotoxins comprising ribosome-inactivating proteins
US5552144A (en) 1992-01-22 1996-09-03 Microcarb, Inc. Immunogenic shiga-like toxin II variant mutants
CA2218601A1 (en) * 1995-03-24 1996-10-03 Ophidian Pharmaceuticals, Inc. Treatment for verotoxin-producing escherichia coli
US6593132B1 (en) * 1997-04-30 2003-07-15 Twinstrand Therapeutics Inc. Ricin-like toxin variants for treatment of cancer, viral or parasitic infections
US7314632B1 (en) * 1997-07-11 2008-01-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pseudomonas exotoxin A-like chimeric immunogens
CA2222993A1 (en) * 1998-02-04 1999-08-04 The Ontario Cancer Institute A method for using a ribosome-inactivating protein complex as a structural template and a molecular search engine in the design, construction and screening of combinatorial protein libraries
AU2001238501A1 (en) * 2000-02-16 2001-08-27 Bechtel Bwxt Idaho, Llc Selective destruction of cells infected with human immunodeficiency virus
AU2001247467A1 (en) * 2000-03-16 2001-09-24 University Of Pittsburgh Peptides targeting specifically tumor-derived endothelial cells
CA2664549A1 (en) * 2005-09-26 2007-03-29 University Health Network Library from toxin mutants, and methods of using same

Also Published As

Publication number Publication date
EP2228383B1 (de) 2012-05-23
ES2344844T3 (es) 2010-09-08
CA2559536A1 (en) 2005-10-06
JP2007531716A (ja) 2007-11-08
EP2228383A1 (de) 2010-09-15
WO2005092917A1 (en) 2005-10-06
AU2004317555B2 (en) 2011-12-01
EP1727827B1 (de) 2010-05-12
JP4934761B2 (ja) 2012-05-16
AU2004317555A1 (en) 2005-10-06
US20070298434A1 (en) 2007-12-27
DE602004027168D1 (de) 2010-06-24
ES2386338T3 (es) 2012-08-17
EP1727827A1 (de) 2006-12-06

Similar Documents

Publication Publication Date Title
DE602004027168D1 (de) Bibliothek von toxin mutanten und deren verwendung
ATE346056T1 (de) Substituierte phenylacetamide und deren verwendung als glucokinaseaktivatoren
ATE463482T1 (de) Chinolinderivate und deren verwendung als mycobakterielle inhibitoren
DK1824855T3 (da) Hidtil ukendte pyrrolo (3,2-d)pyrimidin-4-onderivater og anvendelser af disse til behandling
DE602004021037D1 (de) Phosphororganische indazolderivate und deren verwendung als proteinkinaseinhibitoren
DE60325761D1 (de) Diaminotriazole derivate und deren verwendung als protein kinase inhibitoren
DE60023903D1 (de) Pyrimidin-2,4,6-trionen und deren verwendung als metalloproteinase inhibitoren
EP1539819A4 (de) Verfahren und zusammensetzungen zur erstellung und steuerung des effektorprofils von t-zellen durch gleichzeitiges beladen und aktivieren ausgewählter untergruppen von antigen-präsentierenden zellen
FI20031503A0 (fi) Liukutyyppinen matkapuhelin ja sen liukumenetelmä
DE60332050D1 (de) Zusammensetzung enthaltend lactobacillus oder bifidobacterium und deren verwendung
DE602004021904D1 (de) Gyraseinhibitoren und deren verwendungen
CR9761A (es) Reduccion de celulas b utilizando moleculas de union especificas cd37 y cd20
DE602004030044D1 (de) Bacillus thuringiensis und deren verwendungen
DE60328087D1 (de) Aryl substituierte pyrimidine und deren verwendung
DK2018441T3 (da) Mærkede mikroorganismer og fremgangsmåde til mærkning
DE60317348D1 (de) Pyrimidinderivate und deren verwendung als cb2-modulatoren
DE50111690D1 (de) 2-acyl-indolderivate und deren verwendung als antitumormittel
ATE487707T1 (de) (6-flu0r-benz0äl, 3üdioxolyl)-morpholin-4-yl- methanone und deren verwendung als cbl-liganden
DE60325493D1 (de) Substituierte 1,4-dipiperidin-4-yl-piperazinderivate und deren verwendung als neurokininantagonisten
DE602005009988D1 (de) Härtbare Zusammensetzung und deren Verwendung
DE602004010284D1 (de) Aminochinolinderivate und deren verwendung als adenosin-a3-liganden
ATE472524T1 (de) Diaminoalkohole und deren verwendung als renininhibitoren
DE502004012314D1 (de) Verfahren zum reaktiv-färben von leder, sowie farbstoffe und deren verwendung
DE60332756D1 (de) Anti-infarkt-moleküle
ATE555097T1 (de) 4-cycloalkyl-substituierte tetrahydrochinolinderivate und deren verwendung als medikamente

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties